Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Patient Preference and Adherence
|
June 23, 2026
Sleep Disturbance, Treatment-Related Adverse Events, and Psychological Distress in Breast Cancer Patients: A Prospective Cohort Study
Fang Zhao, Yuqiu Li, Yanjun Zhou, et al.
Therapeutic Advances in Medical Oncology
|
September 11, 2024
Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center study
Mingxia Jiang, Jiaxuan Liu, Maiyue He, et al.
Clinical Rheumatology
|
November 23, 2017
Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis
Jiuliang Zhao, Hongnan Mo, Xiaoxiao Guo, et al.
Translational Oncology
|
November 2, 2024
Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer
Yuhan Wei, Qiao Li, Hongnan Mo, et al.
Molecular Cancer
|
August 30, 2022
S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer
Hongnan Mo, Xuefeng Liu, Yu Xue, et al.
BMC Cancer
|
October 18, 2024
Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study
Jiaxuan Liu, Maiyue He, Mingxia Jiang, et al.
Oncotarget
|
July 23, 2016
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial
Pin Zhang, Yi Yin, Hongnan Mo, et al.
Signal Transduction and Targeted Therapy
|
July 7, 2021
The molecular tumor burden index as a response evaluation criterion in breast cancer
Zongbi Yi, Fei Ma, Guohua Rong, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2025
STS2 deficiency revives CD8<sup>+</sup>T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy
Fangzhou Sun, Fei Ma, Ting Wang, et al.
Annals of Translational Medicine
|
February 11, 2021
Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasis
Yimeng Chen, Yin Guan, Jiayu Wang, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Patient Preference and Adherence
|
June 23, 2026
Sleep Disturbance, Treatment-Related Adverse Events, and Psychological Distress in Breast Cancer Patients: A Prospective Cohort Study
Fang Zhao, Yuqiu Li, Yanjun Zhou, et al.
Therapeutic Advances in Medical Oncology
|
September 11, 2024
Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center study
Mingxia Jiang, Jiaxuan Liu, Maiyue He, et al.
Clinical Rheumatology
|
November 23, 2017
Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis
Jiuliang Zhao, Hongnan Mo, Xiaoxiao Guo, et al.
Translational Oncology
|
November 2, 2024
Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer
Yuhan Wei, Qiao Li, Hongnan Mo, et al.
Molecular Cancer
|
August 30, 2022
S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer
Hongnan Mo, Xuefeng Liu, Yu Xue, et al.
BMC Cancer
|
October 18, 2024
Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study
Jiaxuan Liu, Maiyue He, Mingxia Jiang, et al.
Oncotarget
|
July 23, 2016
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial
Pin Zhang, Yi Yin, Hongnan Mo, et al.
Signal Transduction and Targeted Therapy
|
July 7, 2021
The molecular tumor burden index as a response evaluation criterion in breast cancer
Zongbi Yi, Fei Ma, Guohua Rong, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2025
STS2 deficiency revives CD8<sup>+</sup>T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy
Fangzhou Sun, Fei Ma, Ting Wang, et al.
Annals of Translational Medicine
|
February 11, 2021
Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasis
Yimeng Chen, Yin Guan, Jiayu Wang, et al.
Page
of 6